Key result
The ADD1 Gly460Trp polymorphism (460Trp allele) was not significantly associated with essential hypertension in a South Indian population (OR 1.2, 95% CI 0.9-1.5).
Why the study?
Does the ADD1 Gly460Trp gene polymorphism increase the risk of essential hypertension in an Indian population?
Case-Control (n=893)
No
Does the ADD1 Gly460Trp gene polymorphism increase the risk of essential hypertension in an Indian population?
Odds Ratio: 1.2 (95% CI 0.9–1.5)
Absolute Event Rate: 23% vs 20%
p-value: p=>0.05
The ADD1 Gly460Trp polymorphism is not a significant risk factor for essential hypertension in the South Indian population or in the broader meta-analysis.
Does not support ADD1 Gly460Trp testing for hypertension risk; leaves open population-specific genetic contributions in South Indians.
BACKGROUND: Essential hypertension is a complex genetic trait. Genetic variant of alpha adducin (ADD1) gene have been implicated as a risk factor for hypertension. Given its clinical significance, we investigated the association between ADD1 Gly460Trp gene polymorphism and essential hypertension in an Indian population. Further, a meta-analysis was carried out to estimate the risk of hypertension. METHODS: In the current study, 432 hypertensive cases and 461 healthy controls were genotyped for the Gly460Trp ADD1 gene polymorphism. Genotyping was determined by real time PCR using Taqman assay. Multiple logistic regression analysis was used to detect the association between Gly460Trp polymorphism and hypertension. RESULTS: No significant association was found in the genotype and allele distribution of Gly460Trp polymorphism with hypertension in our study. A total of 15 case-control studies were included in the meta-analysis. There was no evidence of the association of Gly460Trp polymorphism with hypertension in general or in any of the sub group. CONCLUSIONS: We found that the Gly460Trp polymorphism is not a risk factor for essential hypertension in a south Indian Tamilian population. However, the role of ADD1 polymorphism may not be excluded by a negative association study. Further, large and rigorous case-control studies that investigate gene-gene-environment interactions may generate more conclusive claims about the molecular genetics of hypertension.
No takes yet. Share an insight, caveat, or question.
Ramu et al. (2010) conducted a case-control in Essential hypertension (n=893). ADD1 Gly460Trp polymorphism (460Trp allele) vs. Gly460 allele was evaluated on Essential hypertension (OR 1.2, 95% CI 0.9-1.5, p=>0.05). The ADD1 Gly460Trp polymorphism (460Trp allele) was not significantly associated with essential hypertension in a South Indian population (OR 1.2, 95% CI 0.9-1.5).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: